Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex—bound immunogenic peptides induced by interferon-α and interferon-γ treatment of human glioblastoma multiforme-Reference-Cited by-同舟云学术

Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex—bound immunogenic peptides induced by interferon-α and interferon-γ treatment of human glioblastoma multiforme

Published:2004-02 Issue:2 Volume:100 Page:310-319
ISSN:0022-3085
Container-title:Journal of Neurosurgery
language:en
Short-container-title:Journal of Neurosurgery

Author:

Yang Isaac,Kremen Thomas J.,Giovannone Adrian J.,Paik Elena,Odesa Sylvia K.,Prins Robert M.,Liau Linda M.

Publisher

Journal of Neurosurgery Publishing Group (JNSPG)

Link

http://thejns.org/doi/pdf/10.3171/jns.2004.100.2.0310

Reference50 articles.

1. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both α- and γ-interferon

2. Changes in the Immunologic Phenotype of Human Malignant Glioma Cells after Passaging in Vitro

3. Enhanced expression of MHC class I molecules on cultured human thyroid follicular cells infected with reovirus through induction of type 1 interferons

4. IFN-γ-Dependent Inhibition of Tumor Angiogenesis by Tumor-Infiltrating CD4+T Cells Requires Tumor Responsiveness to IFN-γ

5. CELLULAR RESPONSES TO INTERFERON-γ

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the therapeutic prospects of IFNW1 and IFNA21: insights into glioma pathogenesis and clinical significance;Neurogenetics;2024-07-03

2. Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury;Circulation Research;2024-05-10

3. Immunoproteasomal Processing of IsoLG-Adducted Proteins Is Essential for Hypertension;Circulation Research;2024-05-10

4. Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma;Pharmaceutics;2024-04-01

5. Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression;Cancer Cell International;2023-12-08